Insilico Medicine to Showcase AI Drug Discovery Platforms in Dubai and London
Biotechnology firm Insilico Medicine announced its leadership will present advancements in artificial intelligence drug discovery and laboratory robotics at conferences in Dubai and London. Co-Founder and President Dr. Alex Aliper is scheduled to deliver a keynote at Dubai Future Week on closed-loop AI and robotic laboratories. Founder and CEO Dr. Alex Zhavoronkov will participate in panels in London examining China's biopharmaceutical innovation sector.




